US4814434A
(en)
|
1984-02-03 |
1989-03-21 |
Ventres Laboratories, Inc. |
Inducer of T-suppressor cells
|
US5043267A
(en)
|
1984-05-18 |
1991-08-27 |
E. I. Du Pont De Nemours And Company |
Method for rapid detection of bacterial and fungal infection
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US4868103A
(en)
|
1986-02-19 |
1989-09-19 |
Enzo Biochem, Inc. |
Analyte detection by means of energy transfer
|
US4843155A
(en)
|
1987-11-19 |
1989-06-27 |
Piotr Chomczynski |
Product and process for isolating RNA
|
US5077216A
(en)
|
1988-07-06 |
1991-12-31 |
The Trustees Of Dartmouth College |
Monoclonal antibodies specific for a human mononculear phagocyte-specific antigen
|
US5459039A
(en)
|
1989-05-12 |
1995-10-17 |
Duke University |
Methods for mapping genetic mutations
|
DE69326967T2
(de)
|
1992-01-17 |
2000-06-15 |
Lakowicz, Joseph R. |
Phasenmodulationsenergieübertragungsfluoroimmunassay
|
DE69433811T2
(de)
|
1993-01-07 |
2005-06-23 |
Sequenom, Inc., San Diego |
Dns - sequenzierung durch massenspektronomie
|
WO1994021686A1
(en)
|
1993-03-19 |
1994-09-29 |
Northern Sydney Area Health Service |
Papp-a, its immunodetection and uses
|
US5594637A
(en)
|
1993-05-26 |
1997-01-14 |
Base Ten Systems, Inc. |
System and method for assessing medical risk
|
US5498531A
(en)
|
1993-09-10 |
1996-03-12 |
President And Fellows Of Harvard College |
Intron-mediated recombinant techniques and reagents
|
US5514598A
(en)
|
1993-11-30 |
1996-05-07 |
Doody; Michael |
Prenatal detection of meconium
|
US6025395A
(en)
|
1994-04-15 |
2000-02-15 |
Duke University |
Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
|
US7625697B2
(en)
|
1994-06-17 |
2009-12-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for constructing subarrays and subarrays made thereby
|
US6117985A
(en)
|
1995-06-16 |
2000-09-12 |
Stemcell Technologies Inc. |
Antibody compositions for preparing enriched cell preparations
|
US5854033A
(en)
|
1995-11-21 |
1998-12-29 |
Yale University |
Rolling circle replication reporter systems
|
US6031088A
(en)
|
1996-05-23 |
2000-02-29 |
Albert Einstein College Of Medicine Of Yeshiva University |
Polycystic kidney disease PKD2 gene and uses thereof
|
US20030044859A1
(en)
|
1996-08-19 |
2003-03-06 |
Henslee Jerry G. |
Reagents and methods useful for detecting diseases of the breast
|
US20010051341A1
(en)
|
1997-03-04 |
2001-12-13 |
Isis Innovation Limited |
Non-invasive prenatal diagnosis
|
GB9704444D0
(en)
|
1997-03-04 |
1997-04-23 |
Isis Innovation |
Non-invasive prenatal diagnosis
|
US20020119118A1
(en)
|
1997-11-03 |
2002-08-29 |
Genentech, Inc. |
Novel polypeptides and nucleic acids encoding bolekine
|
JPH11118792A
(ja)
|
1997-10-17 |
1999-04-30 |
Ajinomoto Co Inc |
マクロファージの分類方法、免疫性疾患等の検定方法及び免疫性疾患治療剤のスクリーニング方法
|
JP3301963B2
(ja)
|
1998-04-14 |
2002-07-15 |
和久 鍬田 |
重症化侵襲のスクリーニング方法
|
AU1853600A
(en)
|
1999-01-06 |
2000-07-24 |
Choong-Chin Liew |
Method for the detection of gene transcripts in blood and uses thereof
|
US6762032B1
(en)
|
1999-08-23 |
2004-07-13 |
Biocrystal, Ltd. |
Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
|
US20020039736A1
(en)
|
2000-06-05 |
2002-04-04 |
Byrne Michael C. |
Compositions, kits, and methods for identification and modulation of type I diabetes
|
ATE375404T1
(de)
|
2000-06-27 |
2007-10-15 |
Von Recklinghausen Ges E V |
Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose
|
US6631330B1
(en)
|
2000-08-21 |
2003-10-07 |
Assistance Publique-Hopitaux De Paris (Ap-Hp) |
Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
|
AU2126502A
(en)
|
2000-10-03 |
2002-04-15 |
Gene Logic, Inc. |
Gene expression profiles in granulocytic cells
|
US6664056B2
(en)
|
2000-10-17 |
2003-12-16 |
The Chinese University Of Hong Kong |
Non-invasive prenatal monitoring
|
US20020192681A1
(en)
|
2000-10-24 |
2002-12-19 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
FR2816411B1
(fr)
|
2000-11-03 |
2003-07-04 |
Inst Nat Sante Rech Med |
Moyens de detection de la transformation pathologique de la proteine app et leurs applications
|
US7544357B2
(en)
|
2001-01-09 |
2009-06-09 |
Baylor Research Institute |
Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
|
WO2002061434A2
(en)
|
2001-01-29 |
2002-08-08 |
The Center For Blood Research, Inc |
Anergy-regulated molecules
|
US6753137B2
(en)
|
2001-01-31 |
2004-06-22 |
The Chinese University Of Hong Kong |
Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma
|
GB0104690D0
(en)
|
2001-02-26 |
2001-04-11 |
Cytogenetic Dna Services Ltd |
Diagnostic test
|
FR2824144B1
(fr)
|
2001-04-30 |
2004-09-17 |
Metagenex S A R L |
Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
|
EP1389306A2
(de)
|
2001-05-09 |
2004-02-18 |
BioVisioN AG |
Verfahren zum nachweis einer progedienten, chronisch-demenziellen erkrankung, zugehörige peptide und nachweisreagenzien
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
WO2003019193A1
(en)
|
2001-08-30 |
2003-03-06 |
Ciphergen Biosystems, Inc. |
Method of diagnosing nephrotic syndrome
|
US6927028B2
(en)
|
2001-08-31 |
2005-08-09 |
Chinese University Of Hong Kong |
Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
|
US20050095237A1
(en)
|
2001-12-11 |
2005-05-05 |
Emtage Peter C. |
Methods of therapy and diagnosis using targeting of cells that express P2Y10
|
US20040038201A1
(en)
|
2002-01-22 |
2004-02-26 |
Whitehead Institute For Biomedical Research |
Diagnostic and therapeutic applications for biomarkers of infection
|
US6986995B2
(en)
|
2002-02-28 |
2006-01-17 |
Prometheus Laboratories, Inc. |
Methods of diagnosing liver fibrosis
|
US7744876B2
(en)
|
2002-04-09 |
2010-06-29 |
The Curators Of The University Of Missouri |
Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes
|
US7009038B2
(en)
|
2002-05-02 |
2006-03-07 |
Univ. Of Medicine & Dentistry Of N.J. |
pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
|
WO2003094856A2
(en)
|
2002-05-09 |
2003-11-20 |
The Brigham And Women's Hospital, Inc. |
1l1rl-1 as a cardiovascular disease marker and therapeutic target
|
US20040009518A1
(en)
|
2002-05-14 |
2004-01-15 |
The Chinese University Of Hong Kong |
Methods for evaluating a disease condition by nucleic acid detection and fractionation
|
US7157235B2
(en)
|
2002-06-17 |
2007-01-02 |
St. Vincent's Hospital Sydney Limited |
Methods of diagnosis, prognosis and treatment of cardiovascular disease
|
AU2003238193A1
(en)
|
2002-06-26 |
2004-01-19 |
Ralf Herwig |
Method for the determination of characteristics and/or the classification of circulating macrophages, and analysis arrangement for carrying out said method
|
EP1520172A1
(en)
|
2002-07-05 |
2005-04-06 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases
|
FR2844279A1
(fr)
|
2002-09-06 |
2004-03-12 |
Inst Nat Sante Rech Med |
Moyens de detection des processus neurodegeneratifs et leurs applications
|
US20040141969A1
(en)
|
2002-09-16 |
2004-07-22 |
Juergen Floege |
Method for the treatment of nephritis using anti-PDGF-DD antibodies
|
EP1714981A3
(en)
|
2002-10-02 |
2006-12-20 |
F.Hoffmann-La Roche Ag |
Method for the identification of antigenic peptides
|
CA2500652A1
(en)
|
2002-10-02 |
2004-04-15 |
Dmi Biosciences, Inc. |
Diagnosis and monitoring of diseases
|
US20040086864A1
(en)
|
2002-10-22 |
2004-05-06 |
The Chinese University Of Hong Kong |
Novel classification methods for pleural effusions
|
GB0225360D0
(en)
|
2002-10-31 |
2002-12-11 |
Univ London |
Genetic markers
|
US8039218B2
(en)
|
2002-11-14 |
2011-10-18 |
John Wayne Cancer Institute |
Detection of cancer cells in body fluids
|
JP2006514554A
(ja)
|
2002-11-21 |
2006-05-11 |
ワイス |
腎細胞癌および他の固形腫瘍の診断法
|
AU2002952993A0
(en)
|
2002-11-29 |
2002-12-12 |
The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland |
Therapeutic and diagnostic agents
|
ATE533857T1
(de)
|
2003-01-17 |
2011-12-15 |
Univ Hong Kong Chinese |
Zirkulierende mrna als diagnostische marker für erkankungen die mit einer schwangerschaft zusammenhängen
|
WO2004070388A1
(en)
|
2003-02-04 |
2004-08-19 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases
|
US20080107600A1
(en)
|
2003-02-13 |
2008-05-08 |
Taiichi Katayama |
Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same
|
WO2004076639A2
(en)
|
2003-02-26 |
2004-09-10 |
Wyeth |
Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
|
EP1599606A1
(en)
|
2003-03-03 |
2005-11-30 |
Arizona Board of Regents on behalf of The University of Arizona |
Protein tyrosine phosphatase - prl-1 a a marker and therapeutic target for pancreatic cancer
|
WO2005020784A2
(en)
*
|
2003-05-23 |
2005-03-10 |
Mount Sinai School Of Medicine Of New York University |
Surrogate cell gene expression signatures for evaluating the physical state of a subject
|
US7648825B2
(en)
|
2003-06-20 |
2010-01-19 |
University Of Florida Research Foundation, Inc. |
Biomarkers for differentiating between type 1 and type 2 diabetes
|
DE10333406A1
(de)
|
2003-07-15 |
2005-02-10 |
Protagen Ag |
T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen
|
WO2005012907A1
(en)
|
2003-08-01 |
2005-02-10 |
Renovar, Inc. |
Systems and methods for characterizing kidney diseases
|
US7323346B2
(en)
|
2003-08-14 |
2008-01-29 |
The General Hospital Corporation |
Screening for gestational disorders
|
AU2004270220B2
(en)
|
2003-09-05 |
2009-03-05 |
The Chinese University Of Hong Kong |
Method for non-invasive prenatal diagnosis
|
US7445886B2
(en)
|
2003-09-10 |
2008-11-04 |
Board Of Regents, The University Of Texas System |
Macrophage migration inhibitory factor as a marker for cardiovascular risk
|
US20050181386A1
(en)
|
2003-09-23 |
2005-08-18 |
Cornelius Diamond |
Diagnostic markers of cardiovascular illness and methods of use thereof
|
CA2539535A1
(en)
|
2003-10-03 |
2005-04-14 |
Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services |
Use of cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof
|
EP1689884A4
(en)
|
2003-10-08 |
2007-04-04 |
Univ Boston |
METHODS OF PRENATAL DIAGNOSIS OF CHROMOSOMIC ANOMALIES
|
EP1524321B2
(en)
|
2003-10-16 |
2014-07-23 |
Sequenom, Inc. |
Non-invasive detection of fetal genetic traits
|
US7670764B2
(en)
|
2003-10-24 |
2010-03-02 |
Prometheus Laboratories Inc. |
Methods of diagnosing tissue fibrosis
|
ES2411455T3
(es)
|
2003-11-19 |
2013-07-05 |
Rules-Based Medicine, Inc. |
Procedimiento para el diagnóstico y la monitorización de la enfermedad de Alzheimer
|
WO2005050222A1
(en)
|
2003-11-19 |
2005-06-02 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
|
US20060094064A1
(en)
|
2003-11-19 |
2006-05-04 |
Sandip Ray |
Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
|
WO2005072340A2
(en)
|
2004-01-27 |
2005-08-11 |
Compugen Ltd. |
Novel polynucleotides encoding polypeptides and methods using same
|
WO2005075674A1
(en)
|
2004-02-04 |
2005-08-18 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of kcne4 gene and protein for alzheimer disease
|
WO2005082110A2
(en)
|
2004-02-26 |
2005-09-09 |
Illumina Inc. |
Haplotype markers for diagnosing susceptibility to immunological conditions
|
DE102004016437A1
(de)
|
2004-04-04 |
2005-10-20 |
Oligene Gmbh |
Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen
|
US8071552B2
(en)
|
2004-04-05 |
2011-12-06 |
Universite Bordeaux 2 |
Peptides and peptidomimetics binding to CD23
|
US20080051334A1
(en)
|
2004-04-16 |
2008-02-28 |
Evotec Neurosciences Gmbh |
Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative Diseases
|
ES2524309T3
(es)
|
2004-04-20 |
2014-12-05 |
Sphingotec Gmbh |
Utilización de precursores de taquicininas y/o de sus fragmentos en diagnóstico médico
|
AU2005240669A1
(en)
|
2004-05-07 |
2005-11-17 |
Garvan Institute Of Medical Research |
Detecting disease association with aberrant glycogen synthase kinase 3-beta expression
|
JP2007535959A
(ja)
|
2004-05-10 |
2007-12-13 |
エボテツク・ニユーロサイエンシーズ・ゲー・エム・ベー・ハー |
アルツハイマー病のためのkcnj6の診断および治療使用
|
EP2293079B1
(en)
|
2004-05-13 |
2013-08-14 |
B.R.A.H.M.S GmbH |
Use of precursors of enkephalins and/or their fragments in medical diagnostics
|
WO2005113828A1
(en)
|
2004-05-14 |
2005-12-01 |
King Pharmaceuticals Research & Development, Inc. |
Methods of diagnosing and prognosticating solid tumors and melanoma
|
EP1901074B1
(en)
|
2004-05-19 |
2011-07-27 |
Københavns Universitet |
Adam12 as marker for fetal Turner Syndrome
|
US7709194B2
(en)
|
2004-06-04 |
2010-05-04 |
The Chinese University Of Hong Kong |
Marker for prenatal diagnosis and monitoring
|
US20080261258A1
(en)
|
2004-07-09 |
2008-10-23 |
Amaox, Inc. |
Immune Cell Biosensors and Methods of Using Same
|
JP2008506415A
(ja)
|
2004-07-19 |
2008-03-06 |
ユニバーシティー オブ ロチェスター |
神経変性疾患の生物マーカー
|
US20060024724A1
(en)
|
2004-07-30 |
2006-02-02 |
Robert Hussa |
Oncofetal fibronectin as a marker for health and disease
|
EP1789798A4
(en)
|
2004-08-13 |
2009-02-18 |
Xceed Molecular Corp |
MARKER FOR DETECTION OF AUTOIMMUNE DISEASES
|
US7833795B2
(en)
|
2004-08-24 |
2010-11-16 |
The Trustees Of The University Of Pennsylvania |
Assessment of cardiovascular risk using isoprostane biomarkers and COX-2 selective inhibitors
|
US20070087376A1
(en)
|
2004-08-30 |
2007-04-19 |
Potashkin Judith A |
Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseases
|
WO2006032126A1
(en)
|
2004-09-24 |
2006-03-30 |
Syn X Pharma, Inc. |
Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins
|
WO2006050475A2
(en)
|
2004-11-03 |
2006-05-11 |
Brigham And Women's Hospital, Inc. |
Identification of dysregulated genes in patients with neurological diseases
|
WO2006048778A1
(en)
|
2004-11-08 |
2006-05-11 |
King's College London |
Markers of predisposition to addictive states
|
US20060115855A1
(en)
|
2004-12-01 |
2006-06-01 |
Power3 Medical Products, Inc. |
FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease
|
US20060115854A1
(en)
|
2004-12-01 |
2006-06-01 |
Power3 Medical Products, Inc. |
Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease
|
GB0426859D0
(en)
|
2004-12-07 |
2005-01-12 |
Proteome Sciences Plc |
Diagnosis of neurodegenerative disorders
|
EP1825275B1
(en)
|
2004-12-07 |
2010-06-16 |
Electrophoretics Limited |
Diagnosis of neurodegenerative diseases
|
EP1819731A4
(en)
|
2004-12-08 |
2013-02-13 |
Immunomedics Inc |
METHOD AND COMPOSITION FOR IMMUNOTHERAPY AND FOR THE DETECTION OF INFLAMMATORY AND DYSEGRATIVE IMMUNE DISEASES, INFECTION DISEASES, PATHOLOGICAL ANGIOGENESIS AND CANCER
|
JP2008526205A
(ja)
|
2004-12-31 |
2008-07-24 |
ジェネンテック・インコーポレーテッド |
Br3に結合するポリペプチド及びその使用
|
FR2880897B1
(fr)
|
2005-01-18 |
2010-12-17 |
Inst Nat Sante Rech Med |
Methode de detection, non invasive, prenatale, in vitro de l'etat sain normal, de l'etat de porteur sain ou de l'etat de porteur malade de la mucoviscidose
|
US7432107B2
(en)
|
2005-01-24 |
2008-10-07 |
Roche Diagnostics Operations, Inc. |
Cardiac hormones for assessing cardiovascular risk
|
US7572592B2
(en)
|
2005-01-31 |
2009-08-11 |
Glycominds Ltd |
Method for diagnosing multiple sclerosis
|
CA2596518A1
(en)
|
2005-01-31 |
2006-08-10 |
Insilicos, Llc |
Methods of identification of biomarkers with mass spectrometry techniques
|
US20070141625A1
(en)
|
2005-02-03 |
2007-06-21 |
Santos Jose H |
Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies
|
ITRM20050067A1
(it)
|
2005-02-17 |
2006-08-18 |
Istituto Naz Per Le Malattie I |
Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine.
|
WO2006091776A2
(en)
|
2005-02-25 |
2006-08-31 |
The Brigham And Women's Hospital, Inc. |
Biomarkers for predicting prostate cancer progression
|
CA2894337C
(en)
|
2005-03-18 |
2018-08-28 |
The Chinese University Of Hong Kong |
Markers for prenatal diagnosis of trisomy 18
|
JP5219516B2
(ja)
|
2005-03-18 |
2013-06-26 |
ザ チャイニーズ ユニバーシティー オブ ホンコン |
染色体異数性の検出方法
|
US20060257901A1
(en)
|
2005-03-24 |
2006-11-16 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
|
PT1866650E
(pt)
|
2005-04-06 |
2010-06-01 |
Univ Antwerp |
Marcadores neurodegenerativos para a depressão
|
BRPI0610294A2
(pt)
|
2005-04-18 |
2010-06-08 |
Trinity College Dublin |
polipeptìdeos e uso destes
|
WO2006114661A1
(en)
|
2005-04-26 |
2006-11-02 |
Dwek Raymond A |
High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
|
WO2006121952A2
(en)
|
2005-05-05 |
2006-11-16 |
The Regents Of The University Of California |
Diagnostic biomarkers for neurodevelopmental disorders
|
DK1889065T3
(da)
|
2005-05-18 |
2013-09-02 |
Xoma Technology Ltd |
Metoder til diagnostisering og behandling af sygdomme med en autoimmun- og/eller inflammationskomponent
|
US20070015172A1
(en)
|
2005-06-01 |
2007-01-18 |
Z-Biomed, Inc. |
Expression profiles for microbial infection
|
US20070099209A1
(en)
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
GB0512401D0
(en)
|
2005-06-17 |
2005-07-27 |
Randox Lab Ltd |
Method
|
GB2428240A
(en)
|
2005-07-14 |
2007-01-24 |
Univ Gen Ve |
Diagnostic method for brain damage-related disorders
|
US20070148661A1
(en)
|
2005-07-19 |
2007-06-28 |
Duke University |
LSAMP Gene Associated With Cardiovascular Disease
|
TW200712493A
(en)
|
2005-09-28 |
2007-04-01 |
Univ Nat Taiwan |
Tumor marker for ovarian cancer diagnosis
|
IL172297A
(en)
|
2005-10-03 |
2016-03-31 |
Compugen Ltd |
Soluble vegfr-1 variants for the diagnosis of preeclampsia
|
US20070218469A1
(en)
|
2005-10-03 |
2007-09-20 |
Ruth Navon |
Novel mutations in hexosaminidase A
|
AU2006302031A1
(en)
|
2005-10-11 |
2007-04-19 |
Tethys Bioscience, Inc. |
Diabetes-associated markers and methods of use thereof
|
US8652467B2
(en)
|
2005-10-14 |
2014-02-18 |
The Regents Of The University Of Michigan |
Dek protein compositions and methods of using the same
|
AR056786A1
(es)
|
2005-11-10 |
2007-10-24 |
Smithkline Beecham Corp |
Compuesto de 1h- imidazo ( 4,5-c) piridin-2-ilo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion, su uso para preparar unmedicamento, uso de una combinacion que omprende al compuesto y al menos un agente antineoplasico para preparar un medicamento y dicha com
|
TW200726845A
(en)
|
2006-01-02 |
2007-07-16 |
Nat Defense Medical Ct |
Biomarker molecular of renal illness and detecting method for the same
|
EP1808694A1
(en)
|
2006-01-17 |
2007-07-18 |
Universitätsklinikum Freiburg |
Method for diagnosing polycystic kidney disease
|
FR2896588B1
(fr)
|
2006-01-20 |
2016-08-19 |
Univ D'angers |
Methode de diagnostic in vitro de reponse immunitaire autoimmune par detection d'anticorps diriges contre l'antigene pentraxine 3.
|
WO2007090126A2
(en)
|
2006-01-30 |
2007-08-09 |
Invitrogen Corporation |
Compositions and methods for detecting and quantifying toxic substances in disease states
|
US7459280B2
(en)
|
2006-02-27 |
2008-12-02 |
Picobella, Llc |
Methods for diagnosing and treating kidney cancer
|
US8304246B2
(en)
|
2006-02-28 |
2012-11-06 |
Phenomenome Discoveries, Inc. |
Methods for the diagnosis of dementia and other neurological disorders
|
US7488584B2
(en)
|
2006-03-24 |
2009-02-10 |
Picobella |
Methods for diagnosing and treating kidney and colorectal cancer
|
US20070224638A1
(en)
|
2006-03-27 |
2007-09-27 |
Institut Pasteur |
Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
|
GB0606776D0
(en)
|
2006-04-03 |
2006-05-10 |
Novartis Pharma Ag |
Predictive biomarkers for chronic allograft nephropathy
|
EP1847615A1
(en)
|
2006-04-18 |
2007-10-24 |
Genoscreen |
Expression and polymorphism of the ornithine transcarbamylase (OTC) gene as markers for diagnosing Alzheimer's disease
|
US7662578B2
(en)
|
2006-04-21 |
2010-02-16 |
Children's Hospital Medical Center |
Method and kit for the early detection of impaired renal status
|
US20090305265A1
(en)
|
2006-04-27 |
2009-12-10 |
Critical Care Diagnostics, Inc. |
Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
|
ES2380711T3
(es)
|
2006-05-01 |
2012-05-17 |
Critical Care Diagnostics, Inc. |
Diagnóstico de enfermedades cardiovasculares
|
US7901884B2
(en)
|
2006-05-03 |
2011-03-08 |
The Chinese University Of Hong Kong |
Markers for prenatal diagnosis and monitoring
|
US7754428B2
(en)
|
2006-05-03 |
2010-07-13 |
The Chinese University Of Hong Kong |
Fetal methylation markers
|
WO2007131345A1
(en)
|
2006-05-12 |
2007-11-22 |
The Hospital For Sick Children |
Genetic risk factor in sod1 and sfrs15 in renal disease, diabetic cataract, cardiovascular disease and longevity
|
WO2007132512A1
(ja)
|
2006-05-12 |
2007-11-22 |
Keio University |
炎症性疾患の検出並びに炎症性疾患の予防又は治療用組成物
|
ES2429225T3
(es)
|
2006-05-17 |
2013-11-13 |
The Ludwig Institute For Cancer Research |
Anticuerpos anti VEGF-B para tratamiento o profilaxis de diabetes de tipo II o síndrome metabólico
|
US20100009352A1
(en)
|
2006-05-24 |
2010-01-14 |
Gough Albert H |
Method for Modeling a Disease
|
US20080038269A1
(en)
|
2006-05-25 |
2008-02-14 |
Mount Sinai Hospital |
Methods for detecting and treating kidney disease
|
WO2007146229A2
(en)
|
2006-06-07 |
2007-12-21 |
Tethys Bioscience, Inc. |
Markers associated with arteriovascular events and methods of use thereof
|
DE102006027818A1
(de)
|
2006-06-16 |
2007-12-20 |
B.R.A.H.M.S. Aktiengesellschaft |
In vitro Multiparameter-Bestimmungsverfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen
|
WO2008084331A2
(en)
|
2006-06-21 |
2008-07-17 |
Hopitaux Universitaires De Geneve |
Biomarkers for renal disorders
|
WO2008003826A1
(en)
|
2006-07-07 |
2008-01-10 |
Oy Jurilab Ltd |
Novel genes and markers in essential arterial hypertension
|
KR100856375B1
(ko)
|
2006-07-18 |
2008-09-04 |
김현기 |
퇴행성 신경질환 진단용 마커
|
US7851172B2
(en)
|
2006-07-25 |
2010-12-14 |
University Of Kentucky Research Foundation |
Biomarkers of mild cognitive impairment and alzheimer's disease
|
US20080026378A1
(en)
|
2006-07-28 |
2008-01-31 |
Gian Franco Bottazzo |
Prediction and prophylactic treatment of type 1 diabetes
|
US20080113358A1
(en)
|
2006-07-28 |
2008-05-15 |
Ravi Kapur |
Selection of cells using biomarkers
|
ITTO20060614A1
(it)
|
2006-08-21 |
2008-02-22 |
Uni Degli Studi Del Piemonte |
"diagnosi differenziale per la sclerodermia"
|
US20080152589A1
(en)
|
2006-09-08 |
2008-06-26 |
Peter Schofield |
Diagnostics and Therapeutics of Neurological Disease
|
US20090318392A1
(en)
|
2006-09-14 |
2009-12-24 |
Zora Biosciences Oy |
Biofluid metabolite profiling as a tool for early prediction of autoimmunity and type 1 diabetes risk
|
EP1905841A1
(en)
|
2006-09-25 |
2008-04-02 |
Max Delbrück Centrum für Molekulare Medizin (MDC) Berlin-Buch; |
Trex1 as a marker for lupus erythematosus
|
WO2008037449A2
(en)
|
2006-09-26 |
2008-04-03 |
Proteosys Ag |
Use of at least one isoform of progesterone receptor membrane component 1 (pgrmc1)
|
US8110365B2
(en)
|
2006-10-05 |
2012-02-07 |
Rhode Island Hospital |
Compositions and methods for detecting and treating renal injury and inflammation
|
WO2008043725A1
(en)
|
2006-10-10 |
2008-04-17 |
Novartis Ag |
Biomarker in inflammatory disorders
|
US20100029007A1
(en)
|
2006-10-11 |
2010-02-04 |
Novaartis Ag |
Biomarker in Inflammatory Diseases
|
WO2008046512A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Schering Pharma Aktiengesellschaft |
Prss23 as a biomarker, therapeutic and diagnostic target
|
WO2008046511A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Schering Pharma Aktiengesellschaft |
Crtac as a biomarker, therapeutic and diagnostic target
|
WO2008046510A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Healthcare Ag |
Fn1 as a biomarker, therapeutic and diagnostic target
|
EP2102357B1
(en)
|
2006-10-16 |
2013-11-27 |
Bayer Intellectual Property GmbH |
Ltbp2 as a biomarker, therapeutic and diagnostic target
|
US20080261217A1
(en)
|
2006-10-17 |
2008-10-23 |
Melnikov Anatoliy A |
Methylation Profile of Cancer
|
US20100137263A1
(en)
|
2006-10-20 |
2010-06-03 |
Newcastle Innovation Limited |
Assay for the detection of biomarkers associated with pregnancy related conditions
|
CA2668640A1
(en)
|
2006-11-01 |
2008-05-29 |
George Mason Intellectual Properties, Inc. |
Biomarkers for neurological conditions
|
EP2089712A4
(en)
|
2006-11-22 |
2010-09-22 |
Life Technologies Corp |
BIOMARKERS OF AUTOIMMUNE DISEASES
|
WO2008068024A2
(en)
|
2006-12-06 |
2008-06-12 |
Universität Zürich |
Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same
|
US20090104605A1
(en)
|
2006-12-14 |
2009-04-23 |
Gary Siuzdak |
Diagnosis of sepsis
|
IL180095A0
(en)
|
2006-12-14 |
2007-05-15 |
Ohad Birk |
Method for antenatal estimation of down syndrome risk
|
WO2008082519A2
(en)
|
2006-12-19 |
2008-07-10 |
The Trustees Of The University Of Pennsylvania |
Screening for cd93 (c1qrp)-associated polymorphism(s) in the diagnosis, prevention and treatment of autoimmune diseases
|
US8815519B2
(en)
|
2006-12-22 |
2014-08-26 |
Hvidovre Hospital |
Method for predicting cancer and other diseases
|
AU2007342674B2
(en)
|
2007-01-10 |
2013-09-19 |
Purdue Research Foundation |
Polypeptide inhibitors of HSP27 kinase and uses therefor
|
WO2008085024A1
(en)
|
2007-01-12 |
2008-07-17 |
Erasmus University Medical Center Rotterdam |
Identification and detection of peptides relating to specific disorders
|
US8058015B2
(en)
|
2007-01-22 |
2011-11-15 |
Medizinische Universität Innsbruck |
Markers for chronic kidney disease
|
WO2008095261A1
(en)
|
2007-02-08 |
2008-08-14 |
Powmri Limited |
Method of diagnosing a neurodegenerative disease
|
US20080261226A1
(en)
|
2007-02-15 |
2008-10-23 |
Rengang Wang |
Biomarkers of neurodegenerative disease
|
JP5646179B2
(ja)
|
2007-02-21 |
2014-12-24 |
デコード・ジェネティクス・イーエイチエフ |
循環器疾患に関連する遺伝的感受性変異体
|
WO2008112772A2
(en)
|
2007-03-14 |
2008-09-18 |
Baylor Research Institute |
Gene expression in peripheral blood mononuclear cells from children with diabetes
|
EP2134744A2
(en)
|
2007-03-26 |
2009-12-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs
|
EP1975252A1
(en)
|
2007-03-29 |
2008-10-01 |
INSERM (Institut National de la Santé et de la Recherche Medicale) |
Methods for the prognosis or for the diagnosis of a thyroid disease
|
US20120052592A9
(en)
|
2007-03-30 |
2012-03-01 |
Nano Solution, Inc., |
Method for determining prognosis of acute central nervous system disorder
|
MX2009011007A
(es)
|
2007-04-12 |
2009-12-04 |
Apitope Int Nv |
Biomarcadores para esclerosis multiple.
|
GB0707933D0
(en)
|
2007-04-24 |
2007-05-30 |
Apitope Technology Bristol Ltd |
Disease markers
|
GB0708075D0
(en)
|
2007-04-26 |
2007-06-06 |
Univ Nottingham |
Nethods
|
JP5714326B2
(ja)
|
2007-05-01 |
2015-05-07 |
ユニバーシティ オブ マイアミ |
新規に進行中の心不全における個人のリスク評価のためのトランスクリプトームのバイオマーカー
|
CA2685147A1
(en)
|
2007-05-03 |
2008-11-13 |
Medimmune, Llc |
Auto-antibody markers of autoimmune disease
|
WO2008147938A2
(en)
|
2007-05-24 |
2008-12-04 |
Centocor, Inc. |
Wnt5a as an inflammatory disease marker
|
US20100184110A1
(en)
|
2007-06-06 |
2010-07-22 |
Siemens Healthcare Diagnostics Inc. |
Predictive diagnostics for kidney disease
|
US20100184031A1
(en)
|
2007-06-08 |
2010-07-22 |
Geert Raes |
Novel adipocytokine visfatin/pbef1 is an apoptosis associated factor induced in monocytes during in vivo hiv-1 infection
|
US20090142792A1
(en)
|
2007-06-21 |
2009-06-04 |
Robinson William H |
Biomarkers for the diagnosis of autoimmune disease
|
ITRM20070351A1
(it)
|
2007-06-22 |
2008-12-23 |
Istituto Naz Per Le Malattie I |
Gene codificante la proteina ambra 1 avente attivita' regolatoria dell autofagia e dello sviluppo del sistema nervoso centrale
|
WO2009000520A1
(en)
|
2007-06-25 |
2008-12-31 |
Universität Duisburg-Essen |
Screening-method for polymorphic markers in htra1 gene in neurodegenerative disorders
|
EP2167961A4
(en)
|
2007-06-27 |
2010-07-21 |
Univ Leland Stanford Junior |
BETA2-MICROGLOBULIN AND C-REACTIVE PROTEIN (CRP) AS BIOMARKERS FOR PERIPHERAL ARTERY DISEASE
|
US20090258025A1
(en)
|
2007-07-13 |
2009-10-15 |
Genentech, Inc. |
Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders
|
CA2690541A1
(en)
|
2007-07-17 |
2009-01-29 |
Metabolon, Inc. |
Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same
|
CN101815945A
(zh)
|
2007-08-02 |
2010-08-25 |
Iss免疫***刺激股份公司 |
炎性肠病的诊断、分期和监测
|
US20090275046A1
(en)
|
2007-08-29 |
2009-11-05 |
Power3 Medical Products, Inc. |
Complement factor H protein as a biomarker of Parkinson's disease
|
US9086425B2
(en)
|
2007-08-29 |
2015-07-21 |
The Cleveland Clinic Foundation |
Carbamylated proteins and risk of cardiovascular disease
|
US8748100B2
(en)
|
2007-08-30 |
2014-06-10 |
The Chinese University Of Hong Kong |
Methods and kits for selectively amplifying, detecting or quantifying target DNA with specific end sequences
|
GB0717637D0
(en)
|
2007-09-10 |
2007-10-17 |
Univ Leiden |
Future cardiac event biomarkers
|
ITUD20070183A1
(it)
|
2007-10-01 |
2009-04-02 |
Univ Degli Studi Udine |
Metodo diagnostico e prognostico per la diagnosi e la prognosi della linfoproliferazione nelle malattie autoimmuni
|
US8062852B2
(en)
|
2007-10-01 |
2011-11-22 |
The Children's Hospital And Regional Medical Center |
Detection and treatment of autoimmune disorders
|
WO2009050446A1
(en)
|
2007-10-15 |
2009-04-23 |
King's College London |
Viral therapeutic
|
EP2924435A3
(en)
|
2007-10-22 |
2015-11-04 |
The Regents of The University of California |
Biomarkers for prenatal diagnosis of congenital cytomegalovirus
|
FI20070795A0
(fi)
|
2007-10-24 |
2007-10-24 |
Faron Pharmaceuticals Oy |
Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
|
WO2009053537A1
(en)
|
2007-10-26 |
2009-04-30 |
Biohit Oyj |
Methods and products for diagnosing autoimmune diseases and gastric cancer linked with atrophic gastritis
|
WO2009059259A2
(en)
|
2007-10-31 |
2009-05-07 |
Children's Hospital Medical Center |
Detection of worsening renal disease in subjects with systemic lupus erythematosus
|
WO2009058168A1
(en)
|
2007-11-04 |
2009-05-07 |
Prediction Sciences Llc |
Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
|
US20100233716A1
(en)
|
2007-11-08 |
2010-09-16 |
Pierre Saint-Mezard |
Transplant rejection markers
|
US8008013B2
(en)
|
2007-11-16 |
2011-08-30 |
Oklahoma Medical Research Foundation |
Predicting and diagnosing patients with autoimmune disease
|
EP2245188A2
(en)
|
2007-11-28 |
2010-11-03 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Biomarkers for the onset of neurodegenerative diseases
|
US8506933B2
(en)
|
2007-11-30 |
2013-08-13 |
Msdx, Inc. |
Methods of detecting a neurological condition via analysis of circulating phagocytes
|
WO2009074331A2
(en)
|
2007-12-11 |
2009-06-18 |
Julius-Maximilians-Universität Würzburg |
Early and differential diagnosis test for alzheimer's disease
|
WO2009075566A1
(en)
|
2007-12-12 |
2009-06-18 |
Erasmus University Medical Center Rotterdam |
Biomarkers for cardiovascular disease
|
EP2075343A1
(en)
|
2007-12-21 |
2009-07-01 |
Gert Mayer |
A method of diagnosing a progressive disease
|
WO2009083950A2
(en)
|
2007-12-27 |
2009-07-09 |
Compugen Ltd. |
Biomarkers for the prediction of renal injury
|
KR20200091961A
(ko)
|
2008-01-18 |
2020-07-31 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
|
CN101952721A
(zh)
|
2008-01-23 |
2011-01-19 |
里格舒斯匹塔里特医院 |
根据测量生物标记ykl-40的水平所发现的生存预后,对患有心血管疾病的个体的分类
|
WO2009097450A1
(en)
|
2008-01-30 |
2009-08-06 |
Dexcom. Inc. |
Continuous cardiac marker sensor system
|
WO2009100131A2
(en)
|
2008-02-04 |
2009-08-13 |
Banyan Biomarkers, Inc. |
Process to diagnose or treat brain injury
|
MX2010008698A
(es)
|
2008-02-08 |
2010-12-20 |
Medimmune Llc |
Marcadores de enfermedad y usos de los mismos.
|
US20090239242A1
(en)
|
2008-03-18 |
2009-09-24 |
Biotrin Intellectual Properties Limited |
Method for the early identification and prediction of kidney injury
|
AU2008255192A1
(en)
|
2008-03-22 |
2009-10-08 |
Newcastle Innovation Limited |
Detection of a biomarker of aberrant cells of neuroectodermal origin in a body fluid
|
GB0809069D0
(en)
|
2008-05-19 |
2008-06-25 |
Univ Leuven Kath |
Gene signatures
|
EP2107377A1
(en)
|
2008-04-04 |
2009-10-07 |
BRAHMS Aktiengesellschaft |
Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events
|
WO2009122387A1
(en)
|
2008-04-04 |
2009-10-08 |
Biotrin Group Ltd. |
Method for the detection and prediction of obesity-related renal disease
|
ES2502241T3
(es)
|
2008-04-15 |
2014-10-03 |
Oberbauer, Rainer |
Marcadores de fallo renal agudo
|
US8030097B2
(en)
|
2008-04-30 |
2011-10-04 |
Versitech Limited and R & C Biogenius Limited |
Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
|
WO2010005750A2
(en)
|
2008-06-16 |
2010-01-14 |
The Regents Of The University Of California |
Potential prognostic markers and therapeutic targets for neurological disorders
|
US20100167937A1
(en)
|
2008-07-08 |
2010-07-01 |
Power3 Medical Products, Inc. |
Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum
|
EP2853601B1
(en)
|
2008-07-18 |
2016-09-21 |
TrovaGene, Inc. |
Methods for PCR-based detection of "ultra short" nucleic acid sequences
|
WO2010011506A2
(en)
|
2008-07-23 |
2010-01-28 |
The Washington University |
Risk factors and a therapeutic target for neurodegenerative disorders
|
WO2010012306A1
(en)
|
2008-07-31 |
2010-02-04 |
Queen Mary And Westfield College, University Of London |
Healthy kidney biomarkers
|
NO2324360T3
(zh)
|
2008-08-11 |
2018-06-30 |
|
|
ES2341419B1
(es)
|
2008-08-14 |
2011-05-03 |
Hospital Clinic I Provincial De Barcelona |
Wnt1 como biomarcador de daño renal.
|
WO2010022210A2
(en)
|
2008-08-21 |
2010-02-25 |
Pxbiosciences Llc |
Diagnosis and monitoring of renal failure using peptide biomarkers
|
EP2813848A3
(en)
|
2008-08-29 |
2015-03-11 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2161577A1
(en)
|
2008-09-01 |
2010-03-10 |
Atlas Antibodies AB |
ANLN protein
|
WO2010039714A1
(en)
|
2008-09-30 |
2010-04-08 |
Genentech, Inc. |
Biological markers predictive of rheumatoid arthritis response to lymphotoxin antagonists
|
GB0818650D0
(en)
|
2008-10-10 |
2008-11-19 |
Uni I Oslo |
Methods
|
US20100124756A1
(en)
|
2008-10-10 |
2010-05-20 |
Sandip Ray |
Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids
|
NZ619918A
(en)
|
2008-10-21 |
2015-04-24 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
US8778615B2
(en)
|
2008-10-21 |
2014-07-15 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2180322A1
(en)
|
2008-10-22 |
2010-04-28 |
BRAHMS Aktiengesellschaft |
Prognostic biomarkers for the progression of primary chronic kidney disease
|
KR101051435B1
(ko)
|
2008-10-22 |
2011-07-22 |
한국생명공학연구원 |
대장암 관련 마커를 이용한 대장암 진단 키트 및 이를 이용한 대장암 진단 방법
|
WO2010048497A1
(en)
|
2008-10-24 |
2010-04-29 |
Genizon Biosciences Inc. |
Genetic profile of the markers associated with alzheimer's disease
|
US20110212849A1
(en)
|
2008-10-24 |
2011-09-01 |
Vereniging VU-Windesheim; Vereniging voor Christelijk Hoger Onderwijs, |
Biomarkers for predicting the development of chronic autoimmune diseases
|
WO2010054167A2
(en)
|
2008-11-06 |
2010-05-14 |
University Of Miami |
Limited proteolysis of cd2ap and progression of renal disease
|
SG195652A1
(en)
|
2008-11-07 |
2013-12-30 |
Sequenta Inc |
Methods of monitoring conditions by sequence analysis
|
BRPI0922021A2
(pt)
|
2008-11-10 |
2019-09-24 |
Astute Medical Inc |
método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal
|
JP2012508028A
(ja)
|
2008-11-11 |
2012-04-05 |
エンテロス・インコーポレーテッド |
アテローム硬化ポテンシャルを評価するためのバイオマーカー
|
US20120094295A1
(en)
|
2008-11-21 |
2012-04-19 |
The Johns Hopkins University |
Neurodegenerative disease diagnostic compositions and methods of use
|
CN104034901A
(zh)
|
2008-11-22 |
2014-09-10 |
阿斯图特医药公司 |
用于诊断和预后肾损伤和肾衰竭的方法和组合物
|
IT1392551B1
(it)
|
2008-11-25 |
2012-03-09 |
Bioindustry Park Del Canavese S P A |
Biomarcatori per la diagnosi e per rilevare la progressione di malattie neurodegenerative, in particolare della sclerosi laterale amiotrofica
|
EP2370813A4
(en)
|
2008-12-04 |
2012-05-23 |
Univ California |
MATERIALS AND METHODS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER
|
WO2010066000A1
(en)
|
2008-12-09 |
2010-06-17 |
Stephanie Fryar-Williams |
Novel biomarkers
|
EP2406636B1
(en)
|
2008-12-10 |
2018-11-07 |
Joslin Diabetes Center, Inc. |
Methods of diagnosing and predicting renal disease
|
EP2596133A4
(en)
|
2010-07-23 |
2014-04-23 |
Harvard College |
METHODS OF DETECTING NEUROLOGICAL OR NEUROPSYCHIATRIC DISEASES OR DISORDERS
|
EA201390150A1
(ru)
|
2010-07-23 |
2013-09-30 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Способы выявления сигнатур заболевания или патологических состояний в текучих средах организма
|
US20130210647A1
(en)
|
2010-07-23 |
2013-08-15 |
President And Fellows Of Harvard College |
Methods of Detecting Cardiovascular Diseases or Conditions
|
CA2806310A1
(en)
|
2010-07-23 |
2012-01-26 |
President And Fellows Of Harvard College |
Methods of detecting diseases or conditions using phagocytic cells
|
AU2011280997A1
(en)
|
2010-07-23 |
2013-02-28 |
President And Fellows Of Harvard College |
Methods of detecting autoimmune or immune-related diseases or conditions
|
US20130266940A1
(en)
|
2010-07-23 |
2013-10-10 |
President And Fellows Of Harvard College |
Methods of Detecting Kidney-Associated Diseases or Conditions
|
CA2806304A1
(en)
|
2010-07-23 |
2012-01-26 |
President And Fellows Of Harvard College |
Methods of detecting prenatal or pregnancy-related diseases or conditions
|
WO2012016332A1
(en)
|
2010-08-04 |
2012-02-09 |
Med Biogene Inc. |
Prognostic gene signatures for non-small cell lung cancer
|
CA2827894A1
(en)
*
|
2011-02-22 |
2012-08-30 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Circulating biomarkers
|
WO2013003384A1
(en)
|
2011-06-27 |
2013-01-03 |
Dana-Farber Cancer Institute, Inc. |
Signatures and determinants associated with prostate cancer progression and methods of use thereof
|
WO2013188846A1
(en)
|
2012-06-15 |
2013-12-19 |
Harry Stylli |
Methods of detecting diseases or conditions
|
US10015273B2
(en)
|
2014-07-29 |
2018-07-03 |
Open Text Sa Ulc |
Extensible provider connection systems, methods and architecture
|
EP2965086A4
(en)
|
2013-03-09 |
2017-02-08 |
Harry Stylli |
Methods of detecting prostate cancer
|
EP4202441A3
(en)
|
2013-03-09 |
2023-07-26 |
Immunis.AI, Inc. |
Gene expression profile in macrophages for the diagnosis of cancer
|
US10626464B2
(en)
|
2014-09-11 |
2020-04-21 |
Cell Mdx, Llc |
Methods of detecting prostate cancer
|
US9548919B2
(en)
|
2014-10-24 |
2017-01-17 |
Cisco Technology, Inc. |
Transparent network service header path proxies
|